Brief: Cyclo Therapeutics Enters Research And Collaboration Agreement With Wits Commercial Enterprise
24/03/2022 12:55
March 24 (Reuters) - Cyclo Therapeutics Inc CYTH.O :
* CYCLO THERAPEUTICS ENTERS RESEARCH AND COLLABORATION
AGREEMENT
WITH WITS COMMERCIAL ENTERPRISE (PTY) LTD TO EXPLORE POTENTIAL
APPLICATIONS OF TRAPPSOL® CYCLO™ TO EXPAND PIPELINE
Source text for Eikon: ID:nBw75x9MLa
Further company coverage: CYTH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cyclo Therapeutics
See all newsBrief: Rafael Holdings Completes Merger With Cyclo Therapeutics Following Shareholder Approvals
Cyclo Therapeutics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Cyclo Therapeutics Inc Issues $2.5 Million Convertible Promissory Note To Rafael Holdings
U.S. STOCKS ON THE MOVE-McDonald, Uber, SolarWinds
Cyclo Therapeutics jumps on prelim late-stage data of genetic disorder drug